CERo Therapeutics (NASDAQ:CERO) Trading Up 4.6% – Time to Buy?

CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) was up 4.6% during trading on Monday . The stock traded as high as $1.03 and last traded at $0.95. Approximately 435,535 shares changed hands during mid-day trading, an increase of 17% from the average daily volume of 373,681 shares. The stock had previously closed at $0.91.

CERo Therapeutics Stock Down 4.6 %

The business has a fifty day moving average of $1.71 and a two-hundred day moving average of $7.41.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in CERo Therapeutics stock. Avantax Planning Partners Inc. lifted its position in shares of CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) by 89.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 2,585,151 shares of the company’s stock after purchasing an additional 1,224,021 shares during the quarter. Avantax Planning Partners Inc. owned about 172.00% of CERo Therapeutics worth $155,000 as of its most recent filing with the SEC. 29.64% of the stock is owned by institutional investors and hedge funds.

CERo Therapeutics Company Profile

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.